Orthopedic Funding Off to Slower Start in 2025
Through the first four months of the year, orthopedic funding is off to its slowest start in the last decade....
Through the first four months of the year, orthopedic funding is off to its slowest start in the last decade....
The company grew in the mid-teens and could see even greater demand with MACI Arthro's use for trochlea defects....
Insight’s EmbedMed platform digitizes the surgical planning process and allows for rapid design and manufacture of patient-specific guides for orthopedic...
The company's orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise....
The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the...
Stay up to date on the orthopedic market's 1Q performance in 2025 as we update this post with company sales...
The company faced market softness, supply issues and international order timing lumpiness as it declined in the low single digits....
Takeaways, discussion and exhibits from the brand new 2025 edition of our ORTHOPAEDIC INDUSTRY ANNUAL REPORT....
The company's orthopedic sales grew 6% in the first quarter of 2025 on the strength of DUROLANE and Exogen....
The company grew nearly 25% in the first quarter of 2025 as its physician user base reached record levels....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.